Immunosuppressive therapy for autoimmune inner ear disease

Area of Science:

• Immunology
• Otolaryngology
• Rheumatology

Background:

• Autoimmune inner ear disease (AIED) is a rare condition characterized by sensorineural hearing loss and vestibular dysfunction.
• Diagnosis relies on clinical suspicion and response to corticosteroid treatment.
• High-dose corticosteroids remain the primary treatment since AIED's description in 1979.

Purpose of the Study:

• To review the historical development and current research on immunosuppressive therapies for AIED.
• To explore both steroid-based and steroid-sparing treatment options.
• To discuss the role of basic science and clinical research in understanding AIED treatment.

Main Methods:

• Literature review of basic science and clinical studies on AIED treatment.
• Analysis of historical data on corticosteroid efficacy.
• Examination of research on immunosuppressive and steroid-sparing agents.

Main Results:

• Corticosteroids have been the cornerstone of AIED treatment since 1979.
• Animal models have aided in evaluating immunosuppressive strategies.
• Clinical studies explore various steroid and steroid-sparing treatments.

Conclusions:

• Immunosuppressive therapy is crucial for managing AIED.
• Continued research is needed to optimize treatment protocols.
• Understanding the basic science of AIED informs clinical practice.